Zhen Cheng

Title: Zhen Cheng: Innovator in Cancer Immunotherapy

Introduction

Zhen Cheng is a prominent inventor based in Guangdong, China, known for his significant contributions to the field of cancer immunotherapy. With a focus on tumor antigen polypeptides, Cheng has developed innovative solutions aimed at improving cancer diagnosis, prevention, and treatment. His work has led to the filing of two patents that showcase his expertise and commitment to advancing medical science.

Latest Patents

Cheng's latest patents include the "Col14A1-derived tumor antigen polypeptide and use thereof." This patent provides a tumor antigen polypeptide with a specific amino acid sequence, along with a nucleic acid encoding the same. It also details a nucleic acid construct, an expression vector, and a host cell that incorporates the encoding nucleic acid. Furthermore, it discusses the use of the polypeptide, nucleic acid, antigen presenting cell, or immune effector cell in the diagnosis, prevention, and treatment of cancers.

Another notable patent is the "CACNA1H-derived tumor antigen polypeptide and use thereof." Similar to his previous work, this patent outlines a tumor antigen polypeptide with a defined amino acid sequence and includes a nucleic acid encoding the same. It also covers the necessary constructs and cells for presenting the tumor antigen polypeptide, emphasizing its application in cancer diagnosis and treatment.

Career Highlights

Zhen Cheng is currently associated with Genoimmune Therapeutics Co., Ltd., where he continues to push the boundaries of cancer research. His work is characterized by a strong emphasis on the development of innovative therapeutic strategies that harness the body's immune system to combat cancer.

Collaborations

Cheng collaborates with notable colleagues, including Yong Hou and Shuntao Luo, who contribute to his research endeavors and help advance the goals of their projects.

Conclusion

Zhen Cheng's innovative work in the field of cancer immunotherapy, particularly through his patents on tumor antigen polypeptides, positions him as a key figure in the fight against cancer. His contributions are paving the way for new diagnostic and therapeutic approaches that could significantly impact patient outcomes.